LEADERSHIP
Executive Team
Board of Directors
DAN ADAMS, JD
Chairman, EpiVax Therapeutics
ANNE (ANNIE) DE GROOT, MD
Co-Founder, CEO & CSO @ EpiVax
WILLIAM MARTIN, BA
Co-Founder, COO & CIO @ EpiVax
RICHARD LIPKIN, MBA
Managing Director @ Easton Capital
Co-founder of The Catalytic Impact Foundation
ADVISORS
DOMINIQUE BRIDON, PHD
CEO, Diaccurate
Peptide technology expert with over 35 years of experience
MANON COX, PHD, MBA
CEO, NextWaveBio
Scientific and strategic direction
LENNY MOISE, PHD
Director of Vaccines, EpiVax
Leader in T cell epitope-driven vaccine development
AMY ROSENBERG, MD
Senior Director, EpiVax
Former Division Director, CDER, FDA
Regulatory veteran
JUDY LIEBERMAN, MD, PHD
Professor & Chair Immunology, Harvard Medical School
Accomplished immunology expert
ELEANOR RAMOS, MD
CMO/COO, Provention Bio
Clinical development and medical affairs specialist
PARTNERS
NYU LANGONE HEALTH
UNIVERSITY OF CHICAGO
MOUNT SINAI
SYNTHETIC GENOMICS
BROWN UNIVERSITY
IMMUNOMIC THERAPEUTICS
POLYPEPTIDE GROUP
21ST CENTURY
INVESTORS
MORNINGSIDE VENTURES
PRINCETON ALUMNI ANGELS
CATALYTIC IMPACT FOUNDATION
NEXT WAVE BIO
